Global and China Mobile Phone Camera Module Industry 2012 Deep Research Report
2012 Deep Research Report on Global and China Mobile Phone Camera Module Industry> was a professional and depth research report on Global and China Mobile Phone Camera Module, First ly the report introduced mobile Phone Camera Module parts structure and industry chain structure. And then introduced Mobile Phone Camera Module key manufacturing process (CSP COB) and technology, introduced Global and China Camera Lens CMOS Sensor and Mobile Phone Camera Module 2009-2016 Capacity Production manufacturers production market share; and then introduced Camera Lens Sensor Camera Module Supply Demand and Shortage, at the same time, the report also introduced these products selling price Cost Profit Production Value and Gross Margin etc details information. After that, the report listed Camera Lens camera modules camera sensors FPC VCM etc module industry chain related products key manufacturers, introduced their product capacity production price cost profit gross margin and company product specifications etc details information and also showed Mobile Phone Camera Module assemble cost structure and conduct a comprehensive analysis on global and China Mobile Phone Camera Module industry trends. Finally, the report also introduced 50Million Units/year Mobile Phone Camera Module project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and China Mobile Phone Camera Module industry. And thanks to the support and assistance from Mobile Phone Camera Module industry chain related experts and enterprises during QYResearch Research Team survey and interviews.
Browse Full Report: Mobile Phone Camera Module Industry

Table of Contents

Chapter One Mobile Phone Camera Module Industry Overview 1

1.1 Camera Module Classification and Application 1

1.1.1 Lens 1

1.1.2 Image Sensor Chip (CMOS) 2

1.1.3 Backend IC 2

1.1.4 FPC & PCB 2

1.2 Camera Module Industry Chain Structure 2

Chapter Two Mobile Phone Camera Module Manufacturing Process and Technology 3

2.1 Mobile Phone Camera Module CSP(Chip Scale Package) Manufacturing Process 3

2.2 Mobile Phone Camera Module COB(Chip on Board) Manufacturing Process 4

 

Chapter Three Mobile Phone Camera Module Production Supply Sales Demand Market Status and Forecast 4

3.1Mobile Phone Camera Module Productions Overview 6

3.2 Mobile Phone Camera Module Global Production Market Share 9

3.3 Mobile Phone Camera Module China Production Market Share 11

3.4 Global and China Mobile Phone Camera Module Demand Overview 12

3.5 Mobile Phone Camera Module Supply Demand and Shortage 13

3.6 Mobile Phone Camera Module Cost Price Production Value Gross Margin 13

 

Chapter Four Lens and Sensor Production Supply Sales Demand Market Status and Forecast 14

4.1 Camera Lens Production Supply Sales Demand Market Status and Forecast 14

4.1.1 Camera Lens Productions Overview 14

4.1.2 Camera Lens Global Production Market Share 18

4.1.3 Camera Lens China Production Market Share 19

4.1.4 Global and China Camera Lens Demand Overview 20

4.1.5 Global and China Camera Lens Supply Demand Shortage 20

4.1.6 Camera LensCost Price Production Value Gross Margin 21

4.2 Mobile Phone Camera CMOS Image Sensor Production Supply Sales Demand Market Status and Forecast 22

4.2.1 Mobile Phone Camera CMOS Image Sensor Productions Overview 22

4.2.2 Mobile Phone Camera CMOS Image Sensor Global Production Market Share 25

4.2.3 Mobile Phone Camera CMOS Image Sensor China Production Market Share 26

4.2.4 Global and China Mobile Phone Camera CMOS Image Sensor Demand Overview 27

4.2.5 Global and China Mobile Phone Camera CMOS Image Sensor Supply Demand Shortage 28

4.2.6 Mobile Phone Camera CMOS Image SensorCost Price Production Value Gross Margin 28

Browse Report: ICT Market

 Chapter Five Mobile Phone Camera Module Lens Sensor Key Manufacturers 29

5.1 Camera Lens Key Manufacturers 29

5.1.1 Mobile Phone Camera Lens Market Overview 29

5.1.2 Largan Precision (Taiwan) 30

5.1.3 Asia Optical (Taiwan) 33

5.1.4 GSEO (Taiwan) 36

5.1.5 KANTATSU (Japan) 38

5.1.6 KOLEN (Korea) 40

5.1.7 Sekonix (Weihai China) 42

5.1.8 FUJINON (Japan) 44

5.1.9 DIOSTECH (Korea) 46

5.1.10 Sunny Optical (Zhejiang China) 48

5.1.11 Samsung SEM (Korea) 50

5.1.12 Anteryon (Netherlands) 53

5.1.13 Other Manufacturers 54

5.2 Mobile Phone Camera CMOS Image Sensor Key Manufacturers 54

5.2.1 Mobile Phone Camera CMOS Image Sensor Market Overview 54

5.2.2 Mobile Phone Camera CMOS Image Sensor Design Overview 55

5.2.3 Samsung (Korea) 56

5.2.4 OmniVision (USA) 58

5.2.5 APTINA (USA) 61

5.2.6 GALAXYCORE (Shanghai China) 64

5.2.7 STMicroelectronics (Switzerland) 67

5.2.8 SONY (Japan) 68

5.2.9 Hynix (Korea) 71

5.2.10 SETi (Korea) 73

5.2.11 Toshiba (Japan) 75

5.2.12 Sharp (Japan) 78

5.2.13 Pixelplus (Korea) 79

5.2.14 Other Manufacturers 82

5.3 Mobile Phone Camera Module Key Manufacturers 82

5.3.1 Mobile Phone Camera Module Market Overview 82

5.3.2 FOXCONN (Taiwan) 83

5.3.3 Samsung SEM (Korea) 84

5.3.4 OPCOM (Taiwan) 87

5.3.5 LITEON (Taiwan) 89

5.3.6 Truly (HongKong) 91

5.3.7 Sunny Optical (Zhejiang China) 93

5.3.8 Primax (Taiwan) 95

5.3.9 Sharp (Japan) 97

5.3.10 COWELL (Korea) 98

5.3.11 LG INNOTEK (Korea) 102

5.3.12 Other Manufacturers 105

5.4 Backend IC Key Manufacturers 106

5.4.1 Mobile Pohone Image DSP Market Overview 106

5.4.2 TI (USA) 106

5.4.3 Qualcomm (USA) 108

5.4.4 Renesas (Japan) 110

5.4.5 Vimicro (China) 111

5.4.6 STsemiconductor (Switzerland) 113

5.4.7 Nvidia (USA) 114

5.4.13 Other Manufacturers 116

5.5 Mobile Phone Camera Voice Coil Motor (VCM) Key Manufacturers 117

5.5.1 Mobile Phone Camera Voice Coil Motor (VCM) Market Overview 117

5.5.2 SHICON (Japan) 117

5.5.3 HYSONIC (Korea) 118

5.5.4 Sankyo (Japan) 119

5.6 Mobile Phone Camera Flex Printed Circuits (FPC) Key Manufacturers 120

5.6.1 Mobile Phone Camera Flex Printed Circuits Market Overview 120

5.6.2 Career Technology (Taiwan) 120

5.6.3 Ichia (Taiwan) 121

5.6.3 Mektec (Taiwan) 122

5.6.4 COMPLEX MICRO INTERCONNECTION (Taiwan) 123

Chapter Six Mobile Phone Camera Module Cost Analysis 124

6.1 Raw Materials (Lens Sensor FPC etc) Cost Analysis 125

6.2 Power Cost Analysis 125

6.3 Depreciation Cost Analysis 125

6.4 Labor Cost Analysis 126

Read More: Market Research Reports

Chapter Seven China 50 Million Units/Year Mobile Phone Camera Module Project Investment Feasibility Analysis 126

7.1 China Mobile Phone Camera Module Project Opportunities and Risks Analysis 126

7.2 50 Million Units/Year Mobile Phone Camera Module Project Investment Feasibility Analysis 127

7.2.1 Project Name 127

7.2.2 Product and Capacity 127

7.2.3 Key Equipments and Buildings 127

7.2.4 Project Schedule 127

7.2.5 Project Investments 128

7.2.6 Project Investment Feasibility Analysis 128

 

Chapter Eight Mobile Phone Camera Module Research Conclusions 129

» Read More...

Global and China PV Inverter Industry 2012 Deep Research Report
2012 Deep Research Report on Global and China PV Inverter Industry> was published on Mar 2012. It was a professional and depth research report on Global and China PV Inverter Industry. Firstly the report describes the background knowledge of PV Inverter (On-grid Off-grid), including Concepts Classification Manufacturing process technical parameters etc; then statistics International and China 46 Manufacturers PV Inverter product Capacity production cost price production value profit margins and other relevant data, statistics these enterprises PV Inverter products, Product Specifications, company background information, then summary statistics and analysis the relevant data on these enterprises. The report got Global and China PV Inverter companies production market share, Global and China PV Inverter demand supply and shortage, Global and China PV Inverter 2009-2016 production price cost profit production value profit margins, etc. At the same time, the report analyzed and discussed supply and demand changes in PV Inverter market and business development strategies, conduct a comprehensive analysis on China PV Inverter industry trends. Finally, the report also introduced 500MW/year PV Inverter project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and China PV Inverter industry. And thanks to the support and assistance from PV Inverter industry chain related experts and enterprises during QYResearch Solar Energy Research Team survey and interview.
Browse Report: Global and China PV Inverter Industry

Table of Contents

Chapter Five PV Industry Overview 1

1.1 Definition 1

1.2 Classification 2

1.3 Technical Performance 3

1.4 Standards 5

1.5 On-grid Off-Grid PV Inverter 6

1.5.1 On-grid PV Inverter Overview 7

1.5.2 Off-grid PV Inverter Overview 8

Chapter Two PV System and Inverter 9

2.1 PV System Classification and Application 9

2.2 PV Inverter Technical characteristics 11

2.3 PV Inverter Technical Requirement 14

Chapter Three PV Inverter Structure and Technology 14

3.1 Inverter Circuit System 14

3.2 Inverter Structure 15

3.3 PV Inverter Installation and Maintenance 19

3.3.1 Installation Preparation 20

3.3.2 Installation Site Selection 20

3.3.3 Machinery Installation 21

3.3.4 Electrical Connection 22

3.3.5 Operation Check 22

3.3.6 Inverter maintenance 23

3.4 Production Technology of Photovoltaic Inverter 23

3.5 PV Inverter Technology 24

3.6 China and International PV Inverter Technology Comparison and Development Trend 28

3.7 Miniature Inverter 29

3.7.1 Miniature Inverter Characteristic 29

3.7.2 Miniature Inverter Key Technology 30

Chapter Four Inverter Key Component-IGBT 32

4.1 IGBT Overview 32

4.2 Inverter Full Bridge Topology 32

4.3 IGBT Technology 34

4.3.1 High Voltage IGBT 36

4.3.2 Low Voltage IGBT 37

4.4 China IGBT Supply Situation 38

Chapter Five PV Inverter Market Summary 39

5.1 PV Inverter Industry Chain Structure 39

5.2 PV Inverter Market Structure 40

5.3 PV Inverter Industry Analysis 41

5.4 China PV Inverter Market Summary 42

Chapter Six Global and China PV Inverter Production Supply Sales Demand Market Status and Forecast 43

6.1 Global and China PV Inverter Productions Overview 43

6.2 China PV Inverter Domestic Sales Export Import Analysis 56

6.3 China Local Manufacturers Capacity and Production Overview 61

6.4 Global and China PV Inverter (<100KW) (100-250KW) (>250KW) Production Analysis 65

6.5 Global and China PV Inverter Supply Demand and Shortage 68

6.6 2009-2016 Global and China PV Inverter Cost Price Production Value Profit Margin 69

Read More: Power Market

Chapter Seven International PV Inverter Key Manufacturers 70

7.1 SMA (Germany) 70

7.2 Power-One (USA) 84

7.3 KACO (Germany) 90

7.4 Fronius (Australia) 97

7.5 Siemens (Germany) 104

7.6 Satcon (USA) 108

7.7 Advanced Energy (USA) 112

7.8 Schneider (France) 120

7.9 Ingeteam (Spain) 124

7.10 AROS Solar (Italy) 128

7.11 Delta Energy (Germany) 134

7.12 Enphase (USA) 139

7.13 DB POWER (India) 143

7.14 KOSTAL (Germany) 146

7.15 DANFOSS (Denmark) 150

7.16 STECA (Germany) 154

7.17 GREEN POWER (Spain) 157

7.18 GAMESA (Spain) 161

7.19 HELIOS SYSTEMS (Spain) 164

7.20 SILIKEN ELECTRONICS (Spain) 172

7.21 LTI REENERGY (Germany) 176

7.22 JEMA ENERGY (Spain) 180

7.23 ECLIPSE (Italy) 183

7.24 SUNWAYS (Germany) 186

7.25 E-VILLAGE (Germany) 189

7.26 OUTBACK POWER (USA) 193

7.27 AMMINI SOLAR (India) 196

7.28 APOLLO SOLAR (USA) 200

7.29 SOLUTRONIC (Germany) 202

7.30 SOLAR-FABRIK (Germany) 207

Chapter Eight China PV Inverter Key Manufacturers 209

8.1 Sungrow Power (Anhui) 209

8.2 Samil Power (Jiangsu) 217

8.3 Guanya Power (Jiangsu) 222

8.4 Ehexny(Anhui) 226

8.5 ZEVER Solar (Jiangsu) 231

8.6 Growatt (Guangdong) 240

8.7 Corona (Beijing) 244

8.8 JUNENG TECH (Anhui) 248

8.9 XJFTS (Henan) 252

8.10 Kstarnewenergy (Guangdong) 255

8.11 Northern Electric and Power (Shandong) 262

8.12 Jingyi Renewable Energy (Beijing) 266

8.13 CLENERGY (Fujian) 270

8.14 Champion-pv (Guangdong) 273

8.15 CSR Times (Hunan) 278

8.16 Emerson Network (Guangdong) 281

Chapter Nine China PV Inverter Project Investment Feasibility Analysis 284

9.1 PV Inverter Project Opportunities and Risks Analysis 284

9.2 PV Inverter Cost Analysis 286

9.3 500MW PV Inverter Project Feasibility Analysis 287

9.3.1 Project Overview 287

9.3.2 Building 288

9.3.3 Equipment 288

9.3.4 Feasibility Analysis 290

Read More: Market Research Reports

Contact Information:

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
Email: sales@researchmoz.com

» Read More...

According to a new market report published by Transparency Market Research "Pesticides Market : India, China And Japan Industry Analysis, Size, Share & Forecast (2009 - 2016) India, China and Japan pesticide market revenue (collective) reached USD 11.7 billion in 2011 and is expected to reach USD 16.2 billion by 2016, growing at a CAGR of 6.8% from 2011 to 2016. Japan is expected to be the second largest pesticide market after China by 2016.

Based on kind of Pest control the pesticides market is segmented into herbicides, insecticides, fungicides and other pesticides that include nematicides, fumigants and other miscellaneous conventional pesticides, and other chemicals used as pesticides such as sulfur, oil, and sulfuric acid. The pesticides market is highly dynamic with a large number of pesticides products available for use in crop protection.

India pesticides market is highly dynamic as price remains the foremost criterion for the adoption of pesticide. Moreover, lower level of mechanization of farming activities results in higher utilization of manual and traditional pest control methods, which interns lowers the pesticide adoption in India. Unlike China, insecticides segment is the largest pesticide segment both in terms of volume and value.

The China pesticides market is the largest among the three Asian markets, both in terms of revenue and volume consumption. Herbicides segment is the highest contributor towards the China pesticides market and volume consumption and will continue to be the largest segment in China pesticide market throughout the forecast period. Fruits, vegetables and nuts crop segment was the largest consumer of pesticides and will remain so in coming years.

Increasing urbanization has resulted in faster erosion of arable land in Japan. However, increasing demand for food requires higher yield of crop per hectare. To meet the demand, farmers have started using larger volumes of pest control chemicals, resulting into faster growth of pesticides.

This report is an effort to identify factors, which will be the driving force behind the India, China and Japan pesticides market and its sub-markets over the next five years. The report provides extensive analysis of the pesticide industry, current market trends for better understanding of the pesticides market. The study presents a comprehensive assessment of the India, China and Japan pesticide market on the basis of:

Pesticides Types
- Hebrides
- Insecticides
- Fungicides
- Others

Crops
- Cereals
- Fruits, Vegetables and Nuts
- Corn
- Soybean
- Cotton
- Rice
- Others

Countries Covered
- India
- China
- Japan

Browse the detailed TOC at http://www.transparencymarketresearch.com/pesticides-market.html

» Read More...

In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. In the overall Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate (Aclasta/Zometa; Novartis) accounted largest share in class, respectively, and showed an average sales growth rate of about of 20% in the past 2 years.

Browse:  Global Osteoporosis Drug Market

Amgen’s Denosumab is the recent entrant to the Osteoporosis treatment market, following its approval from the U.S. and European Union (also approved for bone loss associated with prostate cancer). Denosumab is expected to compete directly with the Bisphosphonate drug class. However, initial uptake of Denosumab is likely to be as second-line therapy, mostly in patients who are intolerant to Bisphosphonate. In addition to the treatment of Osteoporosis, there is substantial potential for Denosumab for treating bone loss in patients with cancer. Denosumab market is expected to reach USD 3.8 billion in 2015.

Our research indicates that the Osteoporosis drug pipeline is going strong with various phases of clinical development. Phase III has first-in-class products such as odanacatib, which possess a novel mechanism of action to combat Osteoporosis. Aprela is another drug in the stage of development.

The Chinese Osteoporosis drug market is expected to grow at a CAGR of 13.5% from 2010 to 2015. Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug market. The other key growth drivers for Chinese Osteoporosis market include increasing elderly aged population, rising living standards of the Chinese people and increasing awareness and bone health education.

Browse:   Osteoporosis drug market

Geographical analysis of Chinese Osteoporosis drug market shows that there is a huge growth potential for Osteoporosis drug in many cities including Shanghai, Beijing, Guangzhou, and Hangzhou.

To gain a competitive advantage, market players should develop cost-competitive drugs with easy dosage pattern, which promote bone building effectively. Large numbers of patients are unable to comply with the strict dosage schedule of traditional Osteoporosis drugs. Further research and development can address the unmet need by coming up with drugs that have a convenient dosage schedule with better efficacy and safety compared to traditional treatment of Osteoporosis.

After 2012, the Parathyroid Hormone and SERM Osteoporosis drug class market is expected to decline because of anticipated growth of Prolia (Denosumab), which will largely affect other drugs’ market share.

Scope and Overview

The objective of the study on “Global and China Osteoporosis Drug Market Analysis and Forecast (2009 – 2015)” is to gain detailed market insights for key Osteoporosis drugs market segments. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share. The report also covers the strategies followed by “Osteoporosis Drugs Market” players.

Browse:  China Osteoporosis Drug Market

Segmentation & Analysis

The report segments and analyzes the “Osteoporosis Drugs Market” on the basis of following sub-categories:

• Geographic Markets

o Global

o China

• By Segment

o Bisphosphonate Drugs

o SERM Drugs

o Parathyroid Hormone Drugs

o Calcitonin Drugs

o Denosumab Drugs

This section provides in-depth analysis of Osteoporosis Drugs Market size and growth forecast for each drug category, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.

Table Of Content

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 CHINA OSTEOPOROSIS MARKET ANALYSIS, 2009 – 2015

2.1 MARKET OVERVIEW

2.2 50+ CHINESE POPULATION GROWTH TREND 2007 – 2050

2.3 CHINA POPULATION AGE STRUCTURE, 2010

2.4 CHINESE POPULATION WITH OSTEOPOROSIS, 2008 – 2050 (MILLION)

2.5 DRIVING FACTOR ANALYSIS OF CHINA OSTEOPOROSIS MARKET

2.5.1 BARGAINING POWER OF CUSTOMERS: MEDIUM/HIGH

2.5.2 BARGAINING POWER OF SUPPLIERS: LOW

2.5.3 THREAT OF SUBSTITUTE PRODUCTS: MEDIUM

2.5.4 THREAT OF ENTRY OF NEW COMPETITORS: LOW

2.5.5 INTENSITY OF COMPETITIVE RIVALRY: HIGH

2.6 APPROVED OSTEOPOROSIS TREATMENT LANDSCAPE

2.7 COMPETITIVE STRATEGIES

CHAPTER 3 CHINA OSTEOPOROSIS DRUGS MARKET

3.1 MARKET OVERVIEW

3.2 CHINESE OSTEOPOROSIS MARKET ESTIMATE & FORECAST, 2009 – 2015

3.3 DRIVERS

3.3.1 INCREASING AWARENESS OF OSTEOPOROSIS AMONG PATIENTS AS WELL AS                      PHYSICIANS

3.3.2 IMPROVEMENT IN THE RATE OF DIAGNOSIS

3.3.3 BABY BOOMER GENERATION AND INCREASED LIFE EXPECTANCY

3.3.4 HEREDITARY EFFECT AND SEDENTARY LIFESTYLE

3.3.5 SMOKING AND ALCOHOLISM

3.4 RESTRAINTS AND OPPORTUNITIES

3.4.1 REIMBURSEMENT POLICIES

3.4.2 PATIENT AND PHYSICIAN EDUCATION

3.4.3 SIGNIFICANT CLINICAL UNMET NEEDS

3.5 BISPHOSPHONATE DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

3.6 SERM DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

3.7 PARATHYROID HORMONE DRUGS MARKET ANALYSIS & FORECAST, 2010 – 2015

3.8 CALCITONIN DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

3.9 DENOSUMAB DRUGS MARKET ANALYSIS: NOT COMMERCIALIZED

CHAPTER 4 GLOBAL OSTEOPOROSIS DRUGS MARKET ANALYSIS AND FORECAST, 2009 – 2015

4.1 MARKET OVERVIEW

4.2 GLOBAL OSTEOPOROSIS MARKET ESTIMATE & FORECAST, 2009 – 2015

4.3 GLOBAL BISPHOSPHONATE DRUGS MARKET ANALYSIS & FORECAST,

2009 – 2015

4.4 GLOBAL SERM DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

4.5 GLOBAL PARATHYROID HORMONE DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

4.6 GLOBAL CALCITONIN DRUGS MARKET ANALYSIS & FORECAST, 2009 – 2015

4.7 GLOBAL DENOSUMAB DRUGS MARKET ANALYSIS & FORECAST, 2010 – 2015

4.8 PIPELINE DRUGS IN OSTEOPOROSIS MARKET ANALYSIS

4.8.1 ODANACATIB (MK 0822)

4.8.2 APRELA (BAZEDOXIFENE)

CHAPTER 5 RECOMMENDATION

http://www.transparencymarketresearch.com/osteoporosis-drug-market.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Ms Amita

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

http://www.transparencymarketresearch.com/

» Read More...

The prostate cancer minimally invasive surgical device market in North America and Europe is estimated to be $14.2 billion in 2011 and expected to reach $24.9 billion in 2016 at a CAGR of 11.9% over the period 2011 to 2016. The monitoring and visualization segment is the leading market contributor with a share of around 38% in 2011.

Browse full report at:  Minimally Invasive Surgery Market

Prostate cancer is the second most leading cause of cancer associated mortality among men after lung cancer. In 2010, more than 1.9 million people have been diagnosed with the prostate cancer across the world. African Americans and whites are most affected with this disease. Old age, heredity, lifestyle aspects such as smoking and diet rich in red meat are the major factors increasing the risk of getting affected with the disease.

Prostate Cancer Minimally Invasive Surgery Market

The estimated market of North America & Europe minimally invasive prostate cancer surgical device is USD 14.2 billion in 2011 and expected to realize a growth of 11.9% over the period of 2011 to 2016. U.S. is the leading market of minimally invasive prostate cancer surgical devices with an estimated share of around 56% (USD 8 Billion) in 2011and expected to become USD 13 billion (52%) in 2016. Germany is the second high growth market and is the leading market in Europe. It has the estimated market share of about 11% in 2011and is expected to reach USD 3 billion in 2016.

Digital Rectal Exam (DRE), Prostate Biopsy, Prostate Specific Antigen (PSA) blood test, bone scan, ultrasound, CT scan, MRI, lymph node biopsy and ProstaScint monoclonal antibody scanare some of the methods used to diagnose the prostate cancer. Among the surgical techniques, minimally invasive have become quite popular in the last decade.Laparoscopy, cryosurgery, brachytherapy and robotic surgery are the commonly practices surgical techniques while performing minimally invasive surgeries for the treatment of prostate cancer. Laparoscopy has the comparative high adoption rate among the surgeons, while surgical robot has significantly emerged as the top preference in past decade. In spite of high cost of robots (close to USD 1.5 million), their adoption has considerably increased due to better precision, dexterity, improved surgery control, reduced risk of surgical side effects such as impotency, shorter hospital stay, lesser pain, quicker recovery.

Browse: Prostate Cancer Market

Prostate cancer minimally invasive surgery market in North America & Europe is quiteconsolidated. Global players like Ethicon Endo Surgery, Covidien, Intuitive Surgical, Boston Scientific Corporation and Carefusion Corporation holds over 4/5th of the market in 2010. Ethicon Endo Surgery is the market leader with control over 1/3rdof market, followed by Covidien. Further, Intuitive Surgical, Boston Scientific Corporation, Carefusion Corporation and Olympus are closely positioned with shares between 13% and 5%.

Scope and Overview

The objective of the study on “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” is to gain detailed market insights for minimally invasive surgical techniques and devices used to treat prostate cancer in developed economies where the reported cancer incidence is very high. The market is analyzed on the basis of growth trends, ongoing developments, market penetration and revenue share.The report also covers the strategies followed by “Minimally Invasive Prostate cancer Surgery Market in North America and Europe” players.

http://www.transparencymarketresearch.com/prostat-cancer-minimal-invasive-surgery-market.html

» Read More...

Globally as parents are increasingly becoming aware the nutritional requirement in their baby’s food, they are rapidly turning towards more products that enhances the development of their babies throughout the early development stage. Parents with time constraints & concerned about their babies adequate nutrition and all round development are more demanding and also seek clear and timely communication about baby food products.

While birth rates declining in developed markets, new and emerging markets such as India, Brazil and Middle East & African countries has opened up growth gates for baby food market. Enhanced participation of woman in work and fast paced lifestyle has enhanced the adoption of packaged baby food in these regions. Moreover, high competition and growing challenges is also pushing parents to look for high nutritional food for their babies to support their early stage growth. Status symbol also becoming one of the major causes for the adoption of packaged baby food in developing nations.

The Global Baby Food & Pediatric Nutrition Market in 2011 is estimated be worth USD 38,180.9 Million growing with a CAGR of 7.97% during 2007 – 2011 from USD 28,100.0 Million in 2007. The Market is estimated to be worth USD 41,521.7 Million in 2012 and is forecasted to reach USD 63,681.0 Million in 2017. Asia Pacific is expected to account for the largest share of revenue – i.e. 40.20% – of Global Baby Food & Pediatric Nutrition Market revenue at USD 16,692.5 million in 2012. The segment is further expected to reach USD 30,149.1 million in 2017 with a CAGR of 12.55% during 2012 – 2017. The region is also expected to account for largest share of volume – i.e. 37.82% – ofGlobal Baby Food & Pediatric Nutrition Market Volume at 1,223.9 thousand tonnes in 2012. The segment is expected to reach 1,846.3 thousand tonnes in 2017 with a CAGR of 8.57% during 2012 – 2017. The segment is also expected to have the highest growth rate during the same period.

Browse: Baby Food Market Report

The global baby food market is primarily categorized on the basis of products, types, nutritional values and ingredients. This report categorizes the baby food and pediatric nutrition market into seven geographic regions namely: Asia – Pacific, Western Europe, Eastern Europe, North America, Latin America, Middle East & Africa and Australasia.

Contact:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States

Tel: +1-518-618-1030
Tel: +91-20-32405329
Email: sales@transparencymarketresearch.com

http://www.transparencymarketresearch.com/

» Read More...

Movie Name:	Agneepath
Critic Rating:
Viewer Rating:	302 113
Star Cast:	Hrithik Roshan, Sanjay Dutt, Rishi Kapoor, Priyanka Chopra, Zarine Wahab and Om Puri.
Director:	Karan Malhotra
Producer:	Karan Johar and Hiroo Johar.
Music Directer:	Ajay Gogavale and Atul Gogavale.
Genre:	Drama, Action.

StoryStory: Set initially in a village called Mandwa in India, Agneepath which eventually moves to Mumbai, is a simple story of Vijay Dinanath Chauhan (Hrithik Roshan) who wants to take the revenge of his father Dinanath Chauhan’s murder from Kancha (Sanjay Dutt). In the journey to achieve his goal, he stumbles upon Rauf Lala (Rishi Kapoor) who becomes his Godfather. Also, meanwhile, he grows up with girl in neighborhood, Kaali (Priyanka Chopra), who eventually becomes his love interest. Now, how will Vijay accomplish his task is the rest of the story!

Story Treatment: Comparisons are inevitable when a classic like Agneepath is remade. Now, the question remains, will Agneepath surpass the expectations and live up to the hype it has created so far? Well, first of all, current Agneepath isn’t the exact replica of the original one in terms screenplay. New entrants like Rauf Lala add new interesting dimensions to the story. This Hrithik-Sanjay starrer flick is a collage of some impactful moments but fitted in the most haphazard manner which makes it impact less at many moments. Irrelevant sequences like intimacy between Hrithik-Priyanka and overtly dragged brother-sister reunion sequence further add to the misery.

Star Cast: Hrithik Roshan is confidence-personified and complements his counterpart Sanjay Dutt who seemingly looked more powerful as an actor in promos. Sanjay Dutt as Kancha was anticipated to give ‘A’ performance and he lives up to the hype. But, certainly above them is Rishi Kapoor who impresses with his flawless power-packed performance. Priyanka Chopra is brilliant in her small but pivotal role though, the film could survive without her presence. Zarine Wahab and Om Puri play their part well.

Direction: Karan Malhotra still has a long way to go as he comes across as very naïve with his approach towards direction. His act loses threads at most places. But, one can’t take away the credit of creating some historical moments like a beautifully shot fight between Hrithik and Rishi. Also, the way Hrithik reveals his real identity as Dinanath’s son to Kancha through a messenger. And last but not the least, the climax where Vijay takes on Kancha leading to latter’s brutal death. Only thing is wish, these moments were alligned properly with no loopholes to make it a smooth watch for the viewer.

Music/ Cinematography/ Dialogues/ Editing: Barring Chikni Chameli, where Katrina Kaif sets the screen ablaze, none of the songs register. Cinematography gets full marks for capturing the expressions and experimenting with different camera angles. Dialogues are mediocre and crisp editing could have helped in curbing the lengthy duration of the film.

3 Ups and 3 Downs: Stupendous performances, fresh storyline despite a remake, Chikni Chameli song and cinematography are strengths of the film. Music, editing, long duration are the weak points.
On the whole, Agneepath totally rests on star power which will lure the cine-goers to halls but how far will it impress them remains to be seen.

» Read More...

Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. It also includes the devices such as interventional cardiology, cardiac rhythm management, cardiac assist devices, peripheral vascular devices, cardiac surgery, devices used to monitor cardiac events and cardiac prosthetic devices to record the electrophysiological impulses of the heart and to analyze and diagnose any abnormality related to the cardiac function.

Cardiovascular Monitoring and Diagnostic devices are used to detect and provide feedback of abnormal episodes of electrical functioning of the heart. The Cardiovascular  Monitoring & Diagnostic devices include Holter and event recorders, ECG recorders and  ECG stress testing.

Browse: Cardiovascular Diagnostic Devices Market

This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes:

ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.

ECG stress test or Tread Mill Test (TMT) is a diagnostic device used to record the ECG by subjecting the heart to excessive workload. These systems measure the performance of the heart at various stress levels and help physicians in disease diagnosis and deciding treatment protocol.

Event monitors or recorders are devices used to record only the abnormal events of the ECG over an extended period of time.

Holter monitors are devices used to record the ECG for a 24-hour period and to identify abnormal episodes of the ECG.

Browse: Cardiovascular Devices Market

The report forecasts all the sub-categories by regional markets. It also identifies and analyzes the market trends, drivers, inhibitors and opportunities present in each. The key players and their growth strategies have also been analyzed and explained in the  report.

SCOPE OF THE REPORT

The report categorizes global Cardiovascular Monitoring and Diagnostic devices market into four main subcategories: ECG Monitoring Devices, Holter Monitoring Devices, ECG Stress Testing Devices, and Event Monitoring Devices. In addition to market sizes and forecasts, the report identifies and analyzes trends and opportunities for each of the twelve submarkets; providing 48 market tables for submarkets in the U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil.

RESEARCH METHODOLOGY

Key market players were identified using Transparency Market Research, while market sizes were calculated using the bottom-up approach with market trends and penetration percentages verified through various research reports, analysts’ articles, previously published reports on the industry and key competitor companies investor presentations. We also analyzed the annual reports of key players and used their revenues for market estimations.

Browse: Cardiovascular Monitoring Devices Market

OBJECTIVES OF THE RESEARCH

·         Defining and measuring Global Cardiovascular Monitoring and Diagnostic devices market  with respect to products, services and technologies

·         To analyze the market structure by figuring out diverse sub-segments of the Global  Cardiovascular Monitoring and Diagnostic devices market

·         Forecast revenues of the Global Cardiovascular Monitoring and Diagnostic Devices market  and its diverse submarkets with respect to twelve main geographies of the U.S., Canada,  the U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil

·         Recognizing the major market tendency and features driving or hindering growth of the  global Cardiovascular Monitoring and Diagnostic devices market and its diverse  submarkets

·         Strategically analyze each submarket with respect to individual growth trends and  contribution to the overall Cardiovascular Monitoring and Diagnostic devices market

·         Analyze opportunities in the market for stakeholders by identifying high-growth segments  of the global Cardiovascular Monitoring and Diagnostic devices market

·         Follow and evaluate competitive growth like alliances, joint ventures, mergers and  acquisitions in the global Cardiovascular Monitoring and Diagnostic devices industry.

http://www.transparencymarketresearch.com/cardiovascular-monitoring-diagnostic-devices-market.html

» Read More...